News

Published on 13 Nov 2023 on GuruFocus.com via Yahoo Finance

Meta Platforms Inc Takes a Hit in Jeremy Grantham's Latest Portfolio Adjustments

Article preview image

Grantham's Q3 Moves Reflect Strategic Shifts Amid Market Dynamics

Jeremy Grantham (Trades, Portfolio), the seasoned investment strategist and co-founder of Grantham Mayo van Otterloo (GMO) LLC, has made notable changes to his investment portfolio in the third quarter of 2023. Known for his expertise in identifying market bubbles and his cautious approach to investing, Grantham's latest 13F filing reveals a series of strategic buys, sells, and adjustments reflective of his ongoing analysis of market conditions.

Warning! GuruFocus has detected 5 Warning Sign with MSFT.

Read the rest of the article
NASDAQ.ABCM price evolution
NASDAQ.META price evolution
SIX.NOVN price evolution
NYSE.NVS price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Earnings call: Novartis raises 2024 guidance on strong Q3 performance By...

Novartis AG (SIX:NOVN) (NYSE: NVS), a global healthcare company, has reported a solid third-quart...

Investing.com 31 Oct 2024
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment...

On Tuesday, Novartis AG (NYSE:NVS) reported third-quarter sales of $12.823 billion, up 9% (+10% o...

Benzinga · via AOL 31 Oct 2024
Novartis Ag (NVS) Q3 2024 Earnings Call Transcript

*Stock Advisor returns as of October 28, 2024 Vasant Narasimhan -- Chief Executive... Kirsch on t...

The Motley Fool · via AOL 29 Oct 2024
Novartis ups yearly outlook but market focuses on disappointing Pluvicto

, opens new tab raised its 2024 earnings guidance for the third time on Tuesday, buoyed by wider ...

Reuters 29 Oct 2024
Novartis Q3 Earnings Beats Expectations On Strong Sales From Key Drugs, Lifts...

On Tuesday, Novartis AG (NYSE:NVS) reported third-quarter sales of $12.823 billion, up 9% (+10% o...

Benzinga · via Yahoo Finance 29 Oct 2024
Why Is Monte Rosa Therapeutics Stock Surging On Monday?

Monte Rosa Therapeutics Inc (NASDAQ:GLUE) stock is trading higher on Monday after the company...

Benzinga · via AOL 28 Oct 2024
Is Novartis AG (NVS) the Best Cancer Stock to Buy Now?

We recently compiled a list of the 10 Best Cancer Stocks To Buy Now. In this article, we are goin...

Insider Monkey · via Yahoo Finance 24 Aug 2024
Jim Cramer Says It Will Take Time For Novartis AG (NVS) To ‘Get The Attention Of...

We recently compiled a list of the Top 10 Stocks on Jim Cramer’s Radar. In this article, we are...

Insider Monkey · via Yahoo Finance 24 Aug 2024
Novartis AG (NVS): A Cheap Pharmaceutical Stock to Buy According to Short...

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Short Selle...

Insider Monkey · via Yahoo Finance 21 Aug 2024
Novartis AG (NVS): The Best Organ Transplant and Diagnosis Stock According to...

We recently compiled a list of the 10 Best Organ Transplant and Diagnosis Stocks To Buy Now. In t...

Insider Monkey · via Yahoo Finance 24 Jul 2024

Copyright Statfolio @ 2024

Social Accounts